AzTrials
AzTrials

Chronic PainNCT02658474

Multidisciplinary Group Based Treatment of Patients With Chronic Pain

A study testing Acceptance and Commitment Therapy in people with Chronic Pain, run by University of Tromso at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether group based Acceptance and Commitment Therapy (ACT) at a university hospital clinic is superior to treatment in a primary care setting among patients with chronic pain. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Chronic Pain
What is being tested?
Acceptance and Commitment Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
122 participants
Where
1 siteNorway
Study dates
Aug 2016to 2 Oct 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Long-term pain condition over 6 months.
  • Strongest pain ≥ 4 on a scale of 0 to 10.
  • Consent competent and over 18 years
  • Motivated for group-based psychological (ACT) treatment.

Who cannot join

  • Psychiatric illness and behavioral problems, including substance abuse that prevents good group interaction
  • Severe progressive disease

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • University Hospital of North Norway

    Tromsø, Troms, 9038

Other trials in Norway

About this study

Official title: Multidisciplinary Group Based Treatment of Patients With Chronic Pain. A Randomized Controlled Trial Comparing Acceptance Commitment Therapy and Treatment in a Primary Care Setting

The purpose of this study is to determine whether group based Acceptance and Commitment Therapy (ACT) at a university hospital clinic is superior to treatment in a primary care setting among patients with chronic pain.

Hypothesis:

  1. A group based ACT treatment leads to less pain and greater Health Related Quality of Life (HRQOL) in patients with chronic pain than treatment in a primary care setting. ii) The improvement in pain and HRQOL is mediated through an increased degree of pain willingness and involvement in activities. iii) Improvement of pain and HRQOL after the two treatments is associated with demographic, psychosocial and somatic characteristics.
Read the detailed description

Background:

Chronic pain represents a substantial social problem. In Norway, the prevalence of chronic moderate pain is between 25 and 30%, and for severe pain it is at 2%. Multidisciplinary treatment is recommended for chronic pain, and during the last years Acceptance Commitment Therapy (ACT) has been implemented.

Research design, methods and analyses:

One hundred and twenty participants will be recruited from a list of patients referred to the Multidisciplinary Pain Department at the University Hospital of North Norway. Those who meet the defined criteria, are invited to participate. The study has a randomized, semi-crossover design. The participants are allocated to group based ACT or treatment in a primary care setting with a gender stratified, block randomization with a ratio of 1: 1. This means that half of the participants (intervention group, n: 60) get early group based ACT, while the other half (control group, n: 60) will be treated in a primary health care setting. Those of the control group who still meet the criteria, will be offered ACT afterwards.

Data collection will take place at a) start of the study, b) a few days prior to the onset of ACT and c) a few days after ended ACT, and 6 months after the onset of ACT. Data collection is carried out with the same time intervals in the control group. After having received ACT data is collected 12 months after the onset of ACT.

Treatment protocol:

At the first appointment all participants undergo a multidisciplinary evaluation where participants alternate between telling their life story and listening to responses from the multidisciplinary team. The aim is to initiate a reflexive attitude and a feeling of being acknowledged. The multidisciplinary report to the general practitioner provides diagnostic considerations as well as recommendations for future treatment.

  1. Intervention group: Acceptance Commitment Therapy (ACT) is based on the principles of operant conditioning and is less problem-oriented compared with Cognitive Behavioral Therapy (CBT). The patients learn how to accept and to realize that thoughts, feelings and sensations do not have to decide how life is. In a comparative efficacy study ACT has been shown equally effective as CBT.

Mindfulness Based Stress Reduction is included in ACT, and the patients will therefore get a systematic training in mastering stress and emotional conflicts.

B: Control Group: Patients in the control group are primarily treated by the general practitioner supported by recommendations from the multidisciplinary pain team. The treatment will vary in content and form.

Variables:

Electronic data storage: Data will be collected by an internet based system according the the Norwegian regulations for social insurance and are imported and stored anonymized in a password protected SPSS file data at the University Hospital of North Norway.

Variables:

The demographic variables include gender, year of birth, marital status, number of children, education, occupation and employment status, as well as benefits from the social security system (NAV), financial situation and possible compensation or application for disability.

Clinical variables include comorbidity specified by a list of diseases related to the major organ systems.

Pain analyses: Pain intensity is one of two primary outcomes and is measured with four numerical scales for pain intensity (0 being no pain and 10 the worst possible pain) obtained from the Brief Pain Inventory. Localization (specified by a body map) and temporal aspects, duration and variety of pain are also measured

Health related Quality of life: Short form 36 (version 2).

Physical activity: The Gothenburg Activity Question .

Sleep: Insomnia Severity Index is a self-reporting questionnaire that assesses the severity of the sleeping problems. The form contains seven questions answered with a 5 point Likert scale.

Fatigue: Chalder fatigue questionnaire contains 11 questions and operates with 4 answer options with varying degrees of severity.

Anxiety and depression: Hopkins Symptom Checklist 25 with 25 questions about anxiety and depression.

Pain catastrophizing: The Pain Catastrophizing Scale with 13 questions measuring rumination, worst case thinking and helplessness. General Self-Efficacy: General Perceived Self-Efficacy Questionnaire is based on Bandura's model.

Adverse life events: Those who report positively on a severe life event are asked to fill in Impact of Event Scale-6 with 6 questions related to thoughts after traumatic life event.

Specific evaluation of the ACT intervention: The questionnaire Chronic Pain Acceptance Questionnaire (CPAQ 20) includes 20 items selected to assess the degree of pain willingness and involvement in relation to activities.

Use of health services: Type and number of treatments given in and outside the Pain department with waiting time and expectations to treatment.

Drug Consumption: Consumption of non-opioids (paracetamol and NSAIDs), opioids (daily dose is converted to morphine equivalents), and coanalgesics (antidepressants and anticonvulsants) are recorded by a physician.

Statistics: The investigators will perform repeated comparisons of the two treatment groups over a 6 month period, and "within-group" comparisons of ACT treated patients over a 12 month period. The statistical analyses will be carried out in collaboration with a statistician. Comparison analyses between the groups and to baseline as well as predictor analyses will be performed by Mixed models (SPSS).

Power: Based on previously published studies and power calculations from pilot data, a statistical power of 80% and significance level of 5% the investigators will include 120 patients.

Project plan, project, organization and Cooperation:

The project is an independent part in a national multicenter survey of patients treated at multidisciplinary pain departments at university hospitals in Norway. Our project will largely use the same screening measures and outcomes as the national survey.

Ethics: This study compares two established therapy modalities offered to patients referred to the Pain department at the University Hospital of North Norway. The project was approved by the Regional Committee for Medical and Health research ethics 10/12/13.

Conditions
Chronic Pain
Being tested
Acceptance and Commitment Therapy
Keywords
Chronic pain, Acceptance and Commitment Therapy, Multidisciplinary treatment, Group treatment
Medical subject headings
Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Acceptance and Commitment TherapyBehavioural

    Group based Acceptance and Commitment Therapy

Study groups in NCT02658474
Study groupRoleWhat they receive
ACT-groupExperimentalGroup based Acceptance and Commitment Therapy. The patients will attend to three sessions which last for three days. Between the sessions the patients will train at home on ACT related topics. The whole intervention will last for three months.
Receives: Behavioral: Acceptance and Commitment Therapy
Primary careNo interventionTreatment in a primary care setting.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Group difference in pain intensity

    Continuous variable (Numeric rating scale) analyzed by Mixed Model

    Measured: 3 months after baseline

  2. Group difference in pain intensity

    Continuous variable (Numeric rating scale) analyzed by Mixed Model

    Measured: 6 months after baseline

  3. Group difference in health related quality of life

    Health related quality of life is measured by Short Form-36 and analyzed by Mixed Model

    Measured: 3 months after baseline

  4. Group difference in health related quality of life

    Health related quality of life is measured by Short Form-36 and analyzed by Mixed Model

    Measured: 6 months after baseline

Secondary outcomes (11)
  1. Change from baseline in pain intensity

    Continuous variable (Numeric rating scale) analyzed by Mixed Model

    Measured: 3 months after baseline

  2. Change from baseline in pain intensity

    Continuous variable (Numeric rating scale) analyzed by Mixed Model

    Measured: 6 months after baseline

  3. Change from baseline in pain intensity

    Continuous variable (Numeric rating scale) analyzed by Mixed Model

    Measured: 12 months after baseline

  4. Change from baseline in health related quality of life

    Health related quality of life is measured by Short Form-36 and analyzed by Mixed Model

    Measured: 3 months after baseline

  5. Change from baseline in health related quality of life

    Health related quality of life is measured by Short Form-36 and analyzed by Mixed Model

    Measured: 6 months after baseline

  6. Change from baseline in health related quality of life

    Health related quality of life is measured by Short Form-36 and analyzed by Mixed Model

    Measured: 12 months after baseline

  7. Change from baseline in pain willingness and involvement in activities

    The questionnaire Chronic Pain Acceptance Questionnaire (CPAQ 20) and analyzed by Mixed Model

    Measured: 3 months after baseline

  8. Change from baseline in pain willingness and involvement in activities

    The questionnaire Chronic Pain Acceptance Questionnaire (CPAQ 20) and analyzed by Mixed Model

    Measured: 6 months after baseline

  9. Change from baseline in pain willingness and involvement in activities

    The questionnaire Chronic Pain Acceptance Questionnaire (CPAQ 20) and analyzed by Mixed Model

    Measured: 12 months after baseline

  10. Group difference in drug consumption

    Number of analgesics and morphine equivalents analyzed by Mixed Model

    Measured: 6 months after baseline

  11. Group difference in consumption of health services

    Number of health services applied is counted and analyzed by Mixed Model

    Measured: 6 months after baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jan 2016 (estimated)
  2. Study startAug 2016
  3. Primary completion2 Oct 2021
  4. Study completion2 Oct 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
122 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02658474
Sponsor's protocol ID
2013/1880REK
Status last verified
May 2025
First submitted
14 Jan 2016
Last updated
13 May 2025
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Acceptance and Commitment Therapy in people with Chronic Pain, run by University of Tromso at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Group difference in pain intensity (time frame: 3 months after baseline). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in